Rheumatoid arthritis

Capturing Patient Value in an Economic Evaluation

Arthritis Care Res (Hoboken)Published Cost-effectiveness analysis in a real-life cohort

Authors' conclusion

The conventional ICER (eg, EQ-5D) indicates that e-consultations are cost-effective with cost savings of -€161,000 per QALY gained for a prevalent RA cohort treated in a secondary trainee hospital. RA-specific measures show similar results, with ICERs of -€163,000 per HAQ-DI (QALY) and -€223,000 per RAID (QALY) gained.

Study context

Population
Patients with Rheumatoid Arthritis (RA), Maasstad Hospital, the Netherlands (2020–2021)
Participants
772 patients
Exposure
E-consultations vs face-to-face consultations
Outcome
ICER based on EQ-5D compared with ICERs based on RA-specific measures (RAID, HAQ-DI) expressed in QALYs
Methodological detailssingle-centre, economic evaluation, disease-specific measures expressed in quality-adjusted life-years (QALYs) via estimated conversion equations
  • Single-centre
  • Economic evaluation
  • Disease-specific measures expressed in QALYs via estimated conversion equations

Main finding

As reported in the abstract

ICER (cost per QALY gained), e-consultations vs face-to-face

Incremental Cost-Effectiveness Ratio (ICER) based on EQ-5D (cost savings per QALY gained)

-€161,000

ICER based on Health Assessment Questionnaire-Disability Index (HAQ-DI) (QALY)

-€163,000

ICER based on Rheumatoid Arthritis Impact of Disease (RAID) (QALY)

-€223,000

Observational data: associations, not effects.

Original publication

Capturing Patient Value in an Economic Evaluation. Arthritis Care Res (Hoboken). Published 16 December 2023. doi:10.1002/acr.25229

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.